U.S. flag

An official website of the United States government

NM_153026.3(PRICKLE1):c.1621G>T (p.Ala541Ser) AND Epilepsy, progressive myoclonic, 1B

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Aug 28, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000533960.5

Allele description [Variation Report for NM_153026.3(PRICKLE1):c.1621G>T (p.Ala541Ser)]

NM_153026.3(PRICKLE1):c.1621G>T (p.Ala541Ser)

Gene:
PRICKLE1:prickle planar cell polarity protein 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12q12
Genomic location:
Preferred name:
NM_153026.3(PRICKLE1):c.1621G>T (p.Ala541Ser)
HGVS:
  • NC_000012.12:g.42464413C>A
  • NG_012965.1:g.130358G>T
  • NM_001144881.2:c.1621G>T
  • NM_001144882.2:c.1621G>T
  • NM_001144883.2:c.1621G>T
  • NM_153026.3:c.1621G>TMANE SELECT
  • NP_001138353.1:p.Ala541Ser
  • NP_001138354.1:p.Ala541Ser
  • NP_001138355.1:p.Ala541Ser
  • NP_694571.2:p.Ala541Ser
  • NC_000012.11:g.42858215C>A
  • NM_153026.2:c.1621G>T
Protein change:
A541S
Links:
dbSNP: rs763169354
NCBI 1000 Genomes Browser:
rs763169354
Molecular consequence:
  • NM_001144881.2:c.1621G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001144882.2:c.1621G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001144883.2:c.1621G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_153026.3:c.1621G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Epilepsy, progressive myoclonic, 1B
Synonyms:
Progressive myoclonus epilepsy with ataxia; PME
Identifiers:
MONDO: MONDO:0012904; MedGen: C2676254; Orphanet: 308; OMIM: 612437

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000646875Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Aug 28, 2021)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Genetic characteristics of non-familial epilepsy.

Kang KW, Kim W, Cho YW, Lee SK, Jung KY, Shin W, Kim DW, Kim WJ, Lee HW, Kim W, Kim K, Lee SH, Choi SY, Kim MK.

PeerJ. 2019;7:e8278. doi: 10.7717/peerj.8278.

PubMed [citation]
PMID:
31875159
PMCID:
PMC6925949

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240-242.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Invitae, SCV000646875.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

This sequence change replaces alanine with serine at codon 541 of the PRICKLE1 protein (p.Ala541Ser). The alanine residue is highly conserved and there is a moderate physicochemical difference between alanine and serine. This variant is present in population databases (rs763169354, ExAC 0.02%). This missense change has been observed in individual(s) with epilepsy (PMID: 31875159). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 7, 2023